Egalet Corporation has partnered with OraPharma, Inc., a division of Valeant Pharmaceuticals, to co-promote SPRIX Nasal Spray to dentists, dental specialists and oral surgeons across the U.S. OraPharma will begin promoting SPRIX in Q1 2018 as part of a two-year agreement. Financial terms are not disclosed.
No comments:
Post a Comment